Nerve Repair and Re-generation Biomaterials Market REPORT OVERVIEW
- Request a Free Sample to learn more about this report
The global nerve repair and re-generation biomaterials market size was valued USD 309.9 million in 2021 and the market is projected to touch USD 2,156.35 million by 2030, exhibiting with a growing CAGR of 22.5% during the forecast period.
The market for nerve repair and re-generation biomaterials may experience growth-promoting factors as a result of the increasing prevalence of neuro-generative conditions like Alzheimer's, Parkinson's, lateral sclerosis, and others. The technological advancements in the medical field have opened up new opportunities for the market for nerve repair and regeneration to expand. Intraocular lenses (IOLs) are one improvement that is assisting the eye care sector to thrive and increase tremendously. With the aid of new, cutting-edge technology, a number of eye diseases and disorders can be effectively and efficiently treated. This might further accelerate the expansion of the market for nerve repair and re-generation biomaterials. The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.
COVID-19 Impact: Lockdown Gave Rise to Fewer Neurological Diseases Which Hampered the Market
The COVID-19 pandemic has had an influence on the market and on the healthcare systems. Most neurologists are unaware of many infectious diseases, but COVID-19 is a notable exception. Neurologists and other healthcare professionals have been influenced not just in their professional lives but also by the dread and worry it has caused in our own families, our coworkers, our patients and their families, and even in the general public. Elderly people who have underlying chronic diseases are especially vulnerable to serious illness or even death. Neurologists must overcome a number of obstacles to provide patients with neurological diseases with adequate care while minimising the risk of infection.
The nerve repair and regeneration biomaterials used for nerve restoration have been influenced by COVID-19 due to a decline in demand. They are used to treat injuries to the peripheral nerves, including those caused by gunshot wounds, lacerations, penetrating trauma, stretching or crushing trauma, and fractures. The number of accidents on the roads has decreased significantly as a result of the restrictions put in place to stop the spread of COVID-19.
LATEST TRENDS
"The Advancements in The Medical Sciences to Attract the Consumers and Expand the Market"
One of the most potential treatments for injury to peripheral nerves has been found as nerve conduits. Currently used nerve conduits have to choose between mechanical durability and biocompatibility. A bilayered nerve conduit is created using a multi-nozzle additive-lathe 3D bioprinting technique thanks to technological advancements. Gelatin methacrylate (GelMA)-based inner layer that was cellularized using bone marrow mesenchymal stem cells and GelMA(ethylene glycol) diacrylate (PEGDA)-based outer layer make up the printing materials. By modifying the level of methacryloyl substitution and the concentration of GelMA, it was possible to produce BMSCs with good viability and wide morphological spreading in the inner layer. These findings therefore show that 3D bioprinting using an additive-lathe technique of BMSC-embedded bilayered nerve conduits has enormous promise for facilitating peripheral nerve healing.
Nerve Repair and Re-generation Biomaterials Market SEGMENTATION
- Request a Free Sample to learn more about this report
- By Type
Based on type, the nerve repair and re-generation biomaterials market is classified into nerve conduit, nerve wrap, nerve graft and others.
- By Application
Based on application, the nerve repair and re-generation biomaterials market is classified into direct nerve repair/neurorrhaphy, nerve grafting and others.
DRIVING FACTORS
"The Geriatrics Population at Higher Risk of Neurological Orders to Boost the Market "
A rise in patients suffering from a neurological ailment will be indicative of a rise in older persons. The risk of neurologic conditions such stroke, neuropathy, Alzheimer's disease, and Parkinson's disease is increased in the elderly population. Geriatrics make up a significant portion of the total patient population due to their increased susceptibility. The WHO estimates that there were 962 million people in the world who were 60 or older in 2017 and that number will increase to 2.1 billion in 2050. World Population Prospects (2019 Revision) predicts that by 2050, one in four people living in Europe and North America will be 65 years of age or older. Therefore, the need for nerve repair and re-generation biomaterials for the treatment of neurological illnesses has increased due to the development of the senior population segment.
"Rising Prevalence of Neuro-Generative Disorders to Multiply the Market Growth "
The rise in prevalence of neuro-generative diseases including Parkinson's, Alzheimer's, lateral sclerosis, and others may serve as the market for nerve repair and regeneration's growth catalysts. The market for nerve repair and regeneration has new growth opportunities thanks to technological advancements in the healthcare industry. The eye care sector is flourishing and growing impressively because to improvements like intraocular lenses (IOLs). With the aid of new, cutting-edge technology, a number of eye diseases and disorders can be treated successfully and effectively. This could help in the nerve repair and re-generation biomaterials market growth.
RESTRAINING FACTORS
"Disadvantages Associated for Peripheral Nerve Injury Repair to Impede the Market Growth"
The substrate's kinetics of degradation must be in line with the timeframe of the particular tissue's regeneration. To restore the tissue's functionality, the scaffold should ideally be incorporated into the surrounding tissue and progressively replaced by the extracellular matrix and the cells. For instance, excessively quick conduit deterioration can trigger an inflammatory response that results in inadequate nerve regeneration. When nerve healing is finished, conduits should ideally have completely reabsorbed. As a result, the conduit's optimal degradation should be faster at the proximal stump, gradually reducing over time, and slowing down near the distal end.Thus, disadvantages associated with natural-based biomaterials for peripheral nerve injury repair are expected to hamper the nerve repair and re-generation biomaterials market share.
Nerve Repair and Re-generation Biomaterials Market REGIONAL INSIGHTS
- Request a Free Sample to learn more about this report
"North America to Lead the Market with the Rising Incidence of Peripheral Nerve Injuries"
In 2020, North America accounted for the greatest nerve repair and re-generation biomaterials market share, and it is anticipated that it would continue to rule during the forecast period. The increase is due to the increase in neurological illnesses, peripheral nerve damage, and adequate repayment guidelines. Noncommunicable neurological disorders are prevalent and on the rise in the US, with state-to-state variations in prevalence and trends of specific neurological disorders of up to 5 times. There are several factors that are projected to boost demand in the region, including the advanced healthcare infrastructure in nations like Canada and the U.S. and the existence of a sizable patient pool for CNS disorders.
KEY INDUSTRY PLAYERS
"Notable Players to contribute towards the market growth"
The top notch players of the market share are implementing and applying varied front end and back end strategies to exceed and expand their empire.
List of Market Players Profiled
- Axogen (U.S.A)
- Integra (U.S.A)
- Synovis (U.S.A)
- Collagen Matrix (U.S.A)
- Polyganics (Netherlands)
- Checkpoint Surgical (U.S.A)
- Neurotex (U.S.A).
REPORT COVERAGE
The report covers the information on the advancement outlooks with new inventions and SWOT analysis.The market elements situation, with the development areas of the market in the upcoming years. Market segmentation information including the subjective and quantitative research including the effect of financial and strategy viewpoints are discussed in the report. The report also disseminates the information on the regional and nation level assessment incorporating the demand and supply dominators that are affecting the development of the market. The competitive landscape including market share of major players, along with the new research methodologies and strategies adopted by players for the forecasted period is listed in the report.
| REPORT COVERAGE | DETAILS |
|---|---|
Market Size Value In |
US$ 309.9 Million in 2021 |
Market Size Value By |
US$ 2 Million by 2030 |
Growth Rate |
CAGR of 22.5% from 2021 to 2030 |
Forecast Period |
2023-2030 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Types & Application |
Frequently Asked Questions
-
What value is the nerve repair and re-generation biomaterials market expected to touch by 2030?
The global nerve repair and re-generation biomaterials market is expected to reach USD 2,156.35 million by 2030.
-
What CAGR is the nerve repair and re-generation biomaterials market expected to exhibit by 2030?
The nerve repair and re-generation biomaterials market is expected to exhibit a CAGR of 22.5% by 2030.
-
Which are the driving factors of the nerve repair and re-generation biomaterials market?
The geriatrics population at higher risk of neurological orders and the rising prevalence of neuro-generative disorders to drive the nerve repair and re-generation biomaterials market growth.
-
Which are the top companies operating in the nerve repair and re-generation biomaterials market?
AxoGen, Inc.; Stryker Corporation; St. Jude Medical, Inc.; Baxter International, Inc.; Polyganics B.V.; Boston Scientific, Inc.; Integra Lifesciences Corporation; Cyberonics, Inc.; Medtronic plc and others are the top companies operating in the nerve repair and re-generation biomaterials market.
